| NCT00302211 | Actelion | Pulmonary Hypertension | 2006-02-01 | PHASE3 |
| NCT00561223 | University of Oklahoma | Chronic Obstructive Pulmonary Disease|Pulmonary Hypertension | 2006-11 | NA |
| NCT03620526 | National Taiwan University Hospital | Heart Failure With Normal Ejection Fraction | 2017-11-29 | PHASE4 |
| NCT01894035 | Bayer | Pulmonary Hypertension | 2013-09-23 | |
| NCT04123444 | Jakob Stensballe, MD, PhD|Innovation Fund Denmark|Independent Research Fund Denmark | Septic Shock | 2019-10-30 | PHASE2|PHASE3 |
| NCT01598441 | Shanghai Jiao Tong University School of Medicine|Cardiothoracic Surgical Group of Chinese Society of Pediatric Surgery | Pulmonary Hypertension | 2012-06 | PHASE3 |
| NCT04420741 | P?r Johansson | COVID-19|Respiratory Failure | 2020-06-15 | PHASE2 |
| NCT02685618 | P?r Johansson | Cardiac Arrest | 2016-02 | PHASE2 |
| NCT00345501 | Onassis Cardiac Surgery Centre | Renal Insufficiency, Chronic|Coronary Angiography|Angioplasty, Transluminal, Percutaneous Coronary | 2005-11 | PHASE2|PHASE3 |
| NCT00467896 | Actelion | Pulmonary Hypertension | 2006-09 | PHASE2 |
| NCT01274481 | University of Oklahoma|Actelion | Acute Respiratory Distress Syndrome|Acute Lung Injury|Pulmonary Hypertension | 2011-03 | PHASE1 |
| NCT04445246 | Hamad Medical Corporation | COVID-19|ARDS, Human|Hypoxemic Respiratory Failure | 2020-05-23 | PHASE2 |
| NCT00086463 | Actelion | Pulmonary Arterial Hypertension|Ayerza Syndrome|Pulmonary Hypertension | 2004-06 | PHASE2 |
| NCT00709956 | Actelion | Pulmonary Arterial Hypertension | 2008-07 | PHASE3 |
| NCT00109681 | Actelion | Pulmonary Fibrosis|Pulmonary Hypertension | 2005-04 | PHASE2 |
| NCT03293407 | Bayer | Hypertension, Pulmonary | 2018-02-01 | |
| NCT01712997 | Air Force Military Medical University, China | Pulmonary Arterial Hypertension | 2012-09 | PHASE3 |
| NCT04598191 | Yonsei University | Coronary Artery Occlusive Disease | 2020-11-04 | NA |
| NCT04040322 | Civi Biopharma, Inc. | Raynaud´s Phenomenon Secondary to Systemic Sclerosis | 2019-10-14 | PHASE3 |
| NCT00723554 | Actelion | Pulmonary Arterial Hypertension | 2008-07 | PHASE3 |
| NCT04583046 | Yonsei University | Lung Cancer (Including Metastatic Cancer)|Pulmonary Infection | 2020-11-02 | NA |
| NCT01320878 | Shanghai Jiao Tong University School of Medicine | Pulmonary Hypertension | 2007-10 | PHASE2 |
| NCT01549171 | Fertility Specialists of Houston|Origio A+S | Pregnancy | 2010-01 | |
| NCT00250640 | Bayer | Hypertension, Pulmonary | 2005-04 | |
| NCT01971450 | Bayer | Hypertension, Pulmonary | 2013-11-21 | |
| NCT02784899 | Yonsei University | Lung Cancer | 2015-10-08 | NA |
| NCT01468545 | Bayer|Dra. Pilar Escribano Subías - Coordinator - HU 12 de Octubre - Madrid (Spain) | Pulmonary Arterial Hypertension | 2011-10 | |
| NCT03111212 | University Hospital Tuebingen | Respiratory Distress Syndrome, Adult | 2019-06-25 | PHASE3 |
| NCT00004786 | National Center for Research Resources (NCRR)|University of Pittsburgh | Systemic Sclerosis|Raynaud Disease | 1995-12 | PHASE3 |
| NCT00981591 | Seattle Children´s Hospital|Actelion | Pulmonary Hypertension|Neonatal Hypoxic Respiratory Failure|Persistent Pulmonary Hypertension of Newborn|Congenital Heart Defects|Acute Respiratory Distress Syndrome | 2009-09 | PHASE1|PHASE2 |
| NCT01941225 | Louisiana State University Health Sciences Center in New Orleans | Chronic Obstructive Pulmonary Disease | 2013-09 | PHASE2 |
| NCT02482402 | Heidelberg University|Bayer | Chronic Left Ventricular Failure|Pulmonary Hypertension | 2015-02 | PHASE2 |
| NCT01469169 | Bayer | Hypertension, Pulmonary | 2012-06-19 | PHASE3 |
| NCT00235521 | Heidelberg University | Pulmonary Hypertension | 2005-05 | NA |
| NCT00084409 | University of Colorado, Denver|National Cancer Institute (NCI) | Lung Cancer|Precancerous Condition | 2001-11 | PHASE2 |
| NCT03867097 | Civi Biopharma, Inc. | Raynaud Phenomenon Secondary to Systemic Sclerosis | 2019-03-07 | PHASE2 |
| NCT02170519 | Duke University | Pulmonary Hypertension | 2006-09 | PHASE4 |
| NCT03788837 | Assistance Publique - H?pitaux de Paris | Septic Shock Hyperdynamic | 2019-07-03 | PHASE3 |
| NCT00120380 | Hannover Medical School | Hypertension | 2004-09 | PHASE4 |
| NCT04543682 | Charite University, Berlin, Germany | Proximal Humeral Fracture | 2022-05-12 | PHASE1|PHASE2 |
| NCT01062282 | Bayer | Pulmonary Hypertension | 2006-07 | |
| NCT01319045 | University of California, Los Angeles|Actelion | Pulmonary Arterial Hypertension|Congenital Heart Disease|Eisenmenger´s Syndrome | 2011-06 | NA |
| NCT00453414 | Actelion | Pulmonary Arterial Hypertension | 2006-07 | PHASE2 |
| NCT01458041 | Bayer | Peripheral Arterial Disease | 2011-08 | |
| NCT01082484 | University Hospital, Grenoble | Healthy | 2010-01 | PHASE1|PHASE2 |
| NCT00403650 | University of Cincinnati | Sarcoidosis|Pulmonary Arterial Hypertension | 2006-11 | PHASE4 |
| NCT00902603 | Actelion | Pulmonary Arterial Hypertension | 2009-03 | |
| NCT00708565 | VA Loma Linda Health Care System|Actelion | Hypoxic Pulmonary Vasoconstriction | 2008-07 | PHASE1 |
| NCT00439543 | Interstitial Lung Disease Study Group, Korea | Pulmonary Fibrosis|Pulmonary Hypertension | 2007-03 | PHASE2|PHASE3 |
| NCT06319274 | P?r Johansson | Acute Respiratory Failure|Endothelial Dysfunction|Pulmonary Infection | 2024-04-15 | PHASE2 |
| NCT04927039 | Yonsei University | Mediastinal Mass | 2021-06-24 | NA |
| NCT01718288 | Fadoi Foundation, Italy | Peripheral Arterial Disease | 2006-11 | PHASE4 |
| NCT00927654 | Ludwig-Maximilians - University of Munich|Algora | Pulmonary Hypertension | 2009-06 | PHASE3 |
| NCT00409526 | University of Chicago | Pulmonary Hypertension | 2006-12 | PHASE4 |
| NCT03380325 | Amsterdam UMC, location VUmc | Diabetes Mellitus, Type 2|Insulin Sensitivity+Resistance | 2016-05-11 | NA |
| NCT03044314 | Duke University|Actelion | Pulmonary Hypertension | 2017-07-21 | PHASE4 |
| NCT00622687 | Charite University, Berlin, Germany|Schering-Plough | Systemic Sclerosis | 1997-09 | PHASE2 |
| NCT00724321 | Loma Linda University | Hypoxic Pulmonary Vasoconstriction | 2008-07 | PHASE1 |
| NCT01310751 | Shanghai Jiao Tong University School of Medicine | Pulmonary Hypertension | 2011-01 | PHASE2|PHASE3 |
| NCT01054105 | Gachon University Gil Medical Center|Seoul National University Hospital|Seoul National University Bundang Hospital|The Catholic University of Korea|Bayer | Pulmonary Arterial Hypertension | 2010-10 | |
| NCT00216931 | Lund University Hospital|Bayer | Persistent Pulmonary Hypertension|Respiratory Distress Syndrome | 2006-05 | NA |
| NCT03365479 | University of Giessen | Pulmonary Hypertension|Pulmonary Arterial Hypertension | 2017-05-01 | NA |
| NCT03936140 | Seoul St. Mary´s Hospital|The Catholic University of Korea | Lung Cancer | 2018-01-04 | NA |
| NCT03903939 | P?r Johansson|Odense University Hospital|Aarhus University Hospital|Aalborg University Hospital|Oslo University Hospital | Multi Organ Failure | 2019-05-22 | PHASE2 |
| NCT01209533 | Vanderbilt University|Actelion | Asthma | 2010-09 | EARLY_PHASE1 |
| NCT00709098 | Actelion | Pulmonary Arterial Hypertension | 2008-09 | PHASE3 |
| NCT02237183 | National Cancer Institute (NCI) | Lung Carcinoma | 2015-11-05 | PHASE1 |
| NCT07450469 | Institute of Mountain Emergency Medicine | Frostbite|Altitude|Field Physician Care | 2026-05 | |
| NCT01355380 | Bayer | Pulmonary Arterial Hypertension | 2010-08-05 | |
| NCT01437878 | Actelion | Chronic Obstructive Pulmonary Disease|Pulmonary Hypertension | 2012-03 | PHASE2 |
| NCT07263958 | University of Sao Paulo General Hospital | Pulmnary Hypertension|COPD|Pulmonary Hypertension Secondary to Lung Disease and+or Hypoxia | 2025-12-10 | NA |
| NCT01116063 | Carmel Medical Center | Chronic Obstructive Pulmonary Disease | 2010-05 | PHASE4 |